Evaluation of Pemetrexed (Alimta, Ly231514) as Second Line Chemotherapy in Persistent or Recurrent Carcinoma of the Cervix: A Phase Ii Study of the Gynecologic Oncology Group
AuthID
P-00V-T5J
P-00V-T5J